SELLAS Life Sciences SLS
NASDAQ SLS
$11.51 -0.08 (-0.69%)
At close: Sep 29, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) Net Margin (2012 - 2022)

Updated

SELLAS Life Sciences (SLS) reported Net Margin of -4130.10% for FY2022, down 3857.74 percentage points from -272.36% in FY2021.

Analysis

SELLAS Life Sciences (SLS) Net Margin (2012 - 2022) Analysis & Trends

Dating back to FY2013, SELLAS Life Sciences' Net Margin record includes 5 years.

  • The FY2022 figure ranks as the lowest annual Net Margin in data going back to FY2013.
  • According to Business Quant data, Net Margin came in at -272.36% in FY2021 (+613.70 pp) and -886.05% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 21.86%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 21.27%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -8.04%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 22.61%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.81%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 23.62%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 32.99%
10 SELLAS Life Sciences 2.34 Bn 2.34 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -1,674.40%
Jun 30, 2021 -242.79%
Mar 31, 2021 -42.16%
Dec 31, 2020 -195.58%
Jun 30, 2015 -463.04%
Mar 31, 2015 -383.16%
Dec 31, 2014 -249.01%
Sep 30, 2014 -381.05%
Jun 30, 2014 -855.47%
Mar 31, 2014 -116.71%
Dec 31, 2013 -172.64%
Sep 30, 2013 -427.72%
Jun 30, 2013 231.19%
Mar 31, 2013 -759.00%
Sep 30, 2012 -1,540.68%
API Access

SELLAS Life Sciences Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=SLS&period=max&api_key=YOUR_API_KEY